CureLab Veterinary Unveils Breakthrough Gene Therapy for Dogs with Osteoarthritis
Revolutionary Gene Therapy for Dogs
CureLab Veterinary Inc. has recently made headlines with the successful results of its pioneering gene therapy treatment for osteoarthritis in dogs. The treatment, known as ElenaVet™, has exhibited a 90% success rate in alleviating chronic pain associated with osteoarthritis (OA) in a recent study published in Frontiers in Veterinary Science. This groundbreaking research signifies a potential breakthrough in veterinary medicine and offers new hope for pet owners dealing with the daily struggles of their beloved companions suffering from joint pain.
Study Overview
The study involved 17 client-owned dogs diagnosed with OA confirmed through radiographic imaging. Over a span of 10 weeks, these dogs received 1 mg of ElenaVet™ via intramuscular injection each week. The results were exceptional: the Pain Severity Score (PSS) decreased from 5.25 to 3.25, and the Pain Interference Score (PIS) dropped from 7.0 to 3.27 on the Canine Brief Pain Inventory (CBPI) scale.
Remarkably, 90% of the participating dogs met the criteria set by researchers for
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.